Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD

References

• Dicker D, Nguyen G, Abate D, et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1684–1735. doi:10.1016/S0140-6736(18)31891-9
   PubMed Web of Science ®Google Scholar
• Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. doi:10.1016/S0140-6736(18)32335-3
   PubMed Web of Science ®Google Scholar
• Steel N, Ford JA, Newton JN, et al. Changes in health in the countries of the UK and 150 English local authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10158):1647–1661. doi:10.1016/S0140-6736(18)32207-4
   PubMed Web of Science ®Google Scholar
• NHS England. Our ambition for respiratory disease [Internet]; [ cited April 21, 2021]. Available from: https://www.england.nhs.uk/ourwork/clinical-policy/respiratory-disease/. Accessed January 27, 2022.
   Google Scholar
• Aaron SD. Management and prevention of exacerbations of COPD. BMJ. 2014;349:g5237. doi:10.1136/bmj.g5237
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Miravitlles M, Metzdorf N, Celli B. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J COPD. 2017;12:2891–2908. doi:10.2147/COPD.S139470
   Google Scholar
• Donaldson GC, Wedzicha JA. COPD exacerbations · 1: epidemiology. Thorax. 2006;61(2):164–168. doi:10.1136/thx.2005.041806
   PubMed Web of Science ®Google Scholar
• Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–251.
   PubMedGoogle Scholar
• Steer J, Gibson GJ, Bourke SC. Predicting outcomes following hospitalization for acute exacerbations of COPD. QJM. 2010;103(11):817–829. doi:10.1093/qjmed/hcq126
   PubMed Web of Science ®Google Scholar
• Rivera-Fernández R, Navarrete-Navarro P, Fernández-Mondejar E, Rodriguez-Elvira M, Guerrero-López F, Vázquez-Mata G. Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med. 2006;34(9):2317–2324. doi:10.1097/01.CCM.0000233859.01815.38
   PubMed Web of Science ®Google Scholar
• Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358. doi:10.1136/bmj.l5358
   PubMed Web of Science ®Google Scholar
• Ng T-P, Niti M, Tan W-C, Cao Z, Ong KC. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–67. doi:10.1001/archinte.167.1.60
   PubMed Web of Science ®Google Scholar
• Wang Q, Bourbeau J. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology. 2005;10(3):334–340. doi:10.1111/j.1440-1843.2005.00718.x
   PubMed Web of Science ®Google Scholar
• GOLD. Global initiative for chronic obstructive lung disease: pocket guide to COPD diagnosis, management, and prevention, a guide for health care professionals. GOLD. 2017;2017.
   Google Scholar
• Gillespie D, Butler CC, Bates J, et al. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. Br J Gen Pract. 2021;71(705):e266LP–e272. doi:10.3399/BJGP.2020.0823
   Web of Science ®Google Scholar
• Francis NA, Gillespie D, Wootton M, et al. Clinical features and c-reactive protein as predictors of bacterial exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:3147–3158. doi:10.2147/COPD.S265674
   PubMed Web of Science ®Google Scholar
• Butler CC, Gillespie D, White P, et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. N Engl J Med. 2019;381(2):111–120. doi:10.1056/NEJMoa1803185
   PubMed Web of Science ®Google Scholar
• Bates J, Francis NA, White P, et al. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials. 2017;18(1):442. doi:10.1186/s13063-017-2144-8
   PubMed Web of Science ®Google Scholar
• Francis NA, Gillespie D, White P, et al. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT. Health Technol Assess. 2020;24(15): 1–108.
   Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.013.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhou A, Zhao Y, Chen P. Evaluating the clinical COPD questionnaire: a systematic review. Respirology. 2017;22(2):251–262. doi:10.1111/resp.12970
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013;4(2):133–142. doi:10.1111/j.2041-210x.2012.00261.x
   Web of Science ®Google Scholar
• StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019.
   Google Scholar
• Khan A, Dickens AP, Adab P, Jordan RE. Self-management behaviour and support among primary care COPD patients: cross-sectional analysis of data from the Birmingham Chronic Obstructive Pulmonary Disease Cohort. Npj Prim Care Respir Med. 2017;27(1):46. doi:10.1038/s41533-017-0046-6
   PubMed Web of Science ®Google Scholar
• Rockenschaub P, Jhass A, Freemantle N, et al. Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD). J Antimicrob Chemother. 2020;75(1):243–251. doi:10.1093/jac/dkz411
   PubMed Web of Science ®Google Scholar
• Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George respiratory questionnaire. Chest. 2007;132(2):456–463. doi:10.1378/chest.06-0702.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–778. doi:10.1136/thx.42.10.773
   PubMed Web of Science ®Google Scholar
• Aaron SD, Donaldson GC, Whitmore GA, Hurst JR, Ramsay T, Wedzicha JA. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67(3):238LP– 243. doi:10.1136/thoraxjnl-2011-200768.
   Web of Science ®Google Scholar
• Meeraus WH, Mullerova H, El Baou C, Fahey M, Hessel EM, Fahy WA. Predicting re-exacerbation timing and understanding prolonged exacerbations: an analysis of patients with COPD in the ECLIPSE cohort. Int J Chron Obstruct Pulmon Dis. 2021;16:225–244. doi:10.2147/COPD.S279315
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi:10.1164/ajrccm.161.5.9908022
   PubMed Web of Science ®Google Scholar
• Melbye H, Straume B, Aasebø U, Dale K. Diagnosis of pneumonia in adults in general practice. Relative importance of typical symptoms and abnormal chest signs evaluated against a radiographic reference standard. Scand J Prim Health Care. 1992;10(3):226–233. doi:10.3109/02813439209014066
   PubMedGoogle Scholar
• Francis NA, Melbye H, Kelly MJ, et al. Variation in family physicians’ recording of auscultation abnormalities in patients with acute cough is not explained by case mix. A study from 12 European networks. Eur J Gen Pract. 2013;19(2):77–84. doi:10.3109/13814788.2012.733690
   PubMed Web of Science ®Google Scholar
• El-Shafey BI, El-Deib AE. Effect of weight reduction on obese patients with COPD and bronchial asthma. Egypt J Chest Dis Tuberc. 2015;64(4):773–778. doi:10.1016/j.ejcdt.2015.06.007.
   Google Scholar
• McDonald V, Gibson P, Scott H, et al. Obesity in COPD, how should it be managed? - The effect of weight loss and resistance training in obese COPD patients. Eur Respir J. 2014:44(Suppl 58); P3035.
   Google Scholar
• Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J. 2018;52(5):1801261. doi:10.1183/13993003.01261-2018
   PubMed Web of Science ®Google Scholar